| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Neil J. Sebire | Q38549176 |
| Neil W Bulstrode | Q56241474 | ||
| P2093 | author name string | W K Chong | |
| V A Kinsler | |||
| P O'Hare | |||
| T Jacques | |||
| J E Calonje | |||
| D Hargrave | |||
| O Slater | |||
| D Lomas | |||
| P2860 | cites work | Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases | Q28307906 |
| Acute Inhibition of MEK Suppresses Congenital Melanocytic Nevus Syndrome in a Murine Model Driven by Activated NRAS and Wnt Signaling | Q30661575 | ||
| High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi | Q33243184 | ||
| MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children | Q33577613 | ||
| Melanoma risk in congenital melanocytic naevi: a systematic review | Q33997045 | ||
| Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations | Q33998283 | ||
| Great Ormond Street Hospital for Children Registry for congenital melanocytic naevi: prospective study 1988-2007. Part 1-epidemiology, phenotype and outcomes | Q34013879 | ||
| Spectrum of central nervous system abnormalities in neurocutaneous melanocytosis | Q34031334 | ||
| New recommendations for the categorization of cutaneous features of congenital melanocytic nevi. | Q34033621 | ||
| High frequency of BRAF mutations in nevi | Q34160519 | ||
| The incidence and significance of birthmarks in a cohort of 4,641 newborns | Q34266047 | ||
| The incidence of birthmarks in the neonate | Q34461050 | ||
| Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies | Q34716617 | ||
| Mutational analysis of the N-ras, p53, p16INK4a, CDK4, and MC1R genes in human congenital melanocytic naevi | Q35571122 | ||
| Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas | Q35789193 | ||
| Classifying Melanocytic Tumors Based on DNA Copy Number Changes | Q35843508 | ||
| Germline melanocortin-1-receptor genotype is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for MC1R in human fetal development | Q36098992 | ||
| Neurocutaneous melanosis presenting with hydrocephalus. Case report and review of the literature | Q36277580 | ||
| Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool | Q36365473 | ||
| Growth and hormone profiling in children with congenital melanocytic naevi | Q36532499 | ||
| Classification of neurological abnormalities in children with congenital melanocytic naevus syndrome identifies magnetic resonance imaging as the best predictor of clinical outcome | Q36532989 | ||
| Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS | Q36919636 | ||
| Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia | Q37406418 | ||
| Proliferative nodules in a giant congenital melanocytic nevus-case report and review of the literature | Q37612007 | ||
| Large congenital melanocytic nevi: therapeutic management and melanoma risk: a systematic review | Q38062600 | ||
| Molecular pathology of melanocytic tumors | Q38171606 | ||
| Case reports of fatal or metastasizing melanoma in children and adolescents: a systematic analysis of the literature | Q38285394 | ||
| Amplification of mutated NRAS leading to congenital melanoma in neurocutaneous melanocytosis. | Q38844253 | ||
| Age- and site-specific variation in the dermoscopic patterns of congenital melanocytic nevi: an aid to accurate classification and assessment of melanocytic nevi. | Q40181923 | ||
| Copy number abnormalities in new or progressive 'neurocutaneous melanosis' confirm it to be primary CNS melanoma | Q42329085 | ||
| Next-generation sequencing of nevus spilus-type congenital melanocytic nevus: exquisite genotype-phenotype correlation in mosaic RASopathies. | Q42882004 | ||
| Metastatic melanoma in association with a giant congenital melanocytic nevus in an adult: controversial CGH findings | Q46907302 | ||
| BRAF mutations are common somatic events in melanocytic nevi | Q47978923 | ||
| NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi. | Q54239316 | ||
| BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi. | Q54303127 | ||
| Mutational analysis of the BRAF gene in human congenital and dysplastic melanocytic naevi. | Q54641558 | ||
| Nevomelanocytic proliferations in the central nervous system of children | Q72929418 | ||
| Large congenital melanocytic nevi and the risk for development of malignant melanoma and neurocutaneous melanocytosis | Q73031076 | ||
| Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi | Q79777475 | ||
| The association between large congenital melanocytic naevi and cutaneous melanoma: preliminary findings from an Internet-based registry of 379 patients | Q81406937 | ||
| Complications of congenital melanocytic naevi in children: analysis of 16 years' experience and clinical practice | Q81727876 | ||
| RAF around the edges--the paradox of BRAF inhibitors | Q83273681 | ||
| The face in congenital melanocytic nevus syndrome | Q83719724 | ||
| Nodular lesions arising in a large congenital melanocytic naevus in a newborn with eruptive disseminated Spitz naevi | Q84461504 | ||
| Mitotically active proliferative nodule arising in a giant congenital melanocytic nevus: a diagnostic pitfall | Q85952568 | ||
| Naevus spilus-type congenital melanocytic naevus associated with a novel NRAS codon 61 mutation | Q85959635 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | melanoma | Q180614 |
| brain tumor | Q233309 | ||
| melanocytic nevus | Q377568 | ||
| skin neoplasm | Q18921119 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 1131-1143 | |
| P577 | publication date | 2017-04-04 | |
| 2017-05-01 | |||
| P1433 | published in | British Journal of Dermatology | Q4970191 |
| P1476 | title | Melanoma in congenital melanocytic naevi | |
| P478 | volume | 176 |
| Q89758976 | DIAGNOSIS OF ENDOCRINE DISEASE: Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome |
| Q92180963 | Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi |
| Q92435505 | Giant Congenital Melanocytic Nevus Accompanied by an Intracranial Arachnoid Cyst |
| Q33577613 | MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children |
| Q64259715 | Melanoma arising in a Giant congenital melanocytic nevus: two case reports |
| Q64237658 | Melanoma subtypes: genomic profiles, prognostic molecular markers and therapeutic possibilities |
| Q64241169 | Neurocutaneous Melanosis in Association With Large Congenital Melanocytic Nevi in Children: A Report of 2 Cases With Clinical, Radiological, and Pathogenetic Evaluation |
| Q39267197 | Paediatric melanoma |
| Q92782658 | Paediatric melanoma: clinical update, genetic basis, and advances in diagnosis |
| Q89992208 | Surgical treatment of children and youth with congenital melanocytic nevi: self- and proxy-reported opinions |
| Q45955388 | The MeLiM Minipig: An Original Spontaneous Model to Explore Cutaneous Melanoma Genetic Basis. |
| Q100465050 | Transcriptional regulators and alterations that drive melanoma initiation and progression |
| Q57034868 | Use of sedation instead of general anaesthesia for screening MRI in congenital melanocytic naevi under the age of 1 year is a successful, safe, and economical first line approach |
| Q91864626 | cAMP-mediated regulation of melanocyte genomic instability: A melanoma-preventive strategy |
Search more.